Pharma & biotech

Roche to embrace new technologies early on

To Roche, scientific breakthroughs are an important source for developing and launching new treatments. Finding the right time to take in new discoveries is a challenge, says William Pao, head of early clinical research at Roche.
Roche Head of Pharma Research and Early Development (pRED) | Photo: Roche / PR
Roche Head of Pharma Research and Early Development (pRED) | Photo: Roche / PR
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

When Roche's division for early research and development enters into new partnerships, this is oftentimes a way of getting new technologies on board – be they new types of immunotherapy, gene therapy or new RNA technologies.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs